SlideShare a Scribd company logo
1 of 56
Corona virus related MCQ for
examination purpose
Dr. Anjalatchi Muthukumaran
MCQ/objective type /true/false
The first case of corona-virus found in ----
a. Beijing
b. Thailand
c. Wuhan, china
d. Italy
• The first case of corona found outside of
china?
• A. Italy
• B. America
• C. Thailand
• D. Spain
When the first case of corona seen in
India?
• A. 20 January 2020
• B.30 January2020 kerala
• C.1 February 2020
• D.25 January 2020
• Second case seen in –alappuzu kerala
• Third case seen in –kasargodu kerala
When WHO declared officially
declared covid-19 became pandemic?
• A. 9 January 2020
• B.13 January 2020
• C.11 march 2020
• D.30 January 2020
When was COVID-19 first identified?
• On 31 December 2019, WHO was informed of
cases of pneumonia of unknown cause in
Wuhan City, China.
• A novel coronavirus was identified as the
cause by Chinese authorities on 7 January
2020 and was temporarily named “2019-
nCoV”.
• Which organs are most affected by COVID-19?
• The lungs are the organs most affected by
COVID-19 because the virus accesses host
cells via the receptor for the enzyme
angiotensin-converting enzyme 2 (ACE2),
which is most abundant on the surface of type
II alveolar cells of the lungs.
• When was the official name of SARS-CoV-2
announced?
• On 11 February 2020, the International
Committee on Taxonomy of Viruses adopted
the official name "severe acute respiratory
syndrome coronavirus 2" (SARS-CoV-2).
• What is Coronavirus?
A. It is a large family of viruses.
B. It belongs to the family of Nidovirus.
C. Both A and B are correct
D. Only A is correct.
Ans. C
Explanation: Coronaviruses are a large family of
viruses and belong to the Nidovirus family or
Nidovirales order, which includes Coronaviridae,
Arteriviridae, and Roniviridae families.
What does COVID-19 stand for?
• It's a term for Coronavirus Disease 19,
because it's the 19th strain of coronavirus
discovered.
• It's a term that stands for Coronavirus Disease
2019, the year it was first identified.
Janta Curfew declared in India?
• 21 march 2020
• 22 march 2020
• 23 march 2020
• 24 march 2020
• First lockdown Held in – 24 march 2020
• Second lockdown held in -15 April to 3 may
2020
Which area consider as a Hot Pots Area of
corona?
• Red zones
• Yellow zones
• Orange zones
• Green zones
Which are the common diseases related to
corona virus ?
• A. SARS
• B.MERS
• C.Both
• D. None
Incubation period of corona virus?
• A. 2-14days
• B.3-7 days
• C. 2-21 days
• D. 2-28days
When the Indian Air force shower the flower on
corona warriors?
• 22 march 2020
• 5 April 2020
• 3 may 2020
• 3 June 2020
• Which type of disinfectant effective on corona
virus for sanitize purpose?
• 40% alcohol
• Dettol 40 %
• 70% methylspirit
• 60 % ethonol
Which type of disinfectant useful in surface
cleaning purpose on covid -19 exposure?
• A. Phenol
• B. Sodium hypochlorite
• C.Glutaldehyde
• D. Chlorohexidine
• The most common test to detect the corona
virus?
• A. patchy test
• B. antibody test
• C. RT-PCR
• D. both b&c
The most common symptoms of COVID-19 are
• Fever
• Dry cough
• Fatigue
Other symptoms that are less common
and may affect some patients include:
• Loss of taste or smell,
• Nasal congestion,
• Conjunctivitis (also known as red eyes)
• Sore throat,
• Headache,
• Muscle or joint pain,
• Different types of skin rash,
• Nausea or vomiting,
• Diarrhea,
• Chills or dizziness.
Symptoms of severe COVID‐19 disease
include:
• Shortness of breath,
• Loss of appetite,
• Confusion,
• Persistent pain or pressure in the chest,
• High temperature (above 38 °C).
Which of the following statements regarding Isolation during COVID-19
is/are correct?
1. It is used for people suffering from COVID-19 symptoms or who have tested
positive for the virus.
2. In isolation means being separated from other people, mainly in a medical
facility where you can receive clinical care.
A. Only 1
B. Only 2
C. Both 1 and 2
D. Neither 1 nor 2
Ans. C
• Explanation: Isolation is used for those people who have COVID-19
symptoms or who have tested positive. In isolation means being separated
from other people, mainly in a medical facility where you can receive
clinical care. As per WHO, if any person has symptoms then he or she
should remain in isolation for at least 10 days plus an additional 3 days
without symptoms. If a person is infected and does not develop symptoms
then he or she should remain in isolation for 10 days from the time he or
she test positive.
• Consider the following statements.
• 1. When a virus does not change is called a mutation.
2. A virus with one or more new mutations is known as a “variant”
of the original virus.
Which of the following statements is/are correct?
A. Only 1
B. Only 2
C. Both 1 and 2
D. Neither 1 nor 2
Ans. B
Explanation: When a virus replicates makes copies of itself sometimes
changes a little bit which is normal for a virus. These changes are
known as mutations and a virus with one or more new mutations is
known as a "variant" of the original virus.
How does Coronavirus transmit?
A. When a person sneezes or coughs, droplets spread in
the air or fall on the ground and nearby surfaces.
B. If another person is nearby and inhales the droplets
or touches these surfaces and further touches his
face, eyes, or mouth, he or she can get an infection.
C. If the distance is less than 1 meter from the infected
person.
D. D. All the above are correct.
Ans. D
Explanation: Coronavirus (COVID-19) transmits
through the above-mentioned options.
The first case of novel coronavirus
was identified in .....
A. Beijing
B. Shanghai
C. C. Wuhan, Hubei
D. D. Tianjin
E. Ans. C
Explanation: The first case of novel
coronavirus was identified in Wuhan, Hubei
Province, China.
From where coronavirus got its
name?
• A. Due to their crown-like projections.
B. Due to their leaf-like projections.
C. Due to their surface structure of bricks.
D. None of the above
In which age group the COVID-19 spreads?
A. COVID-19 occurs in all age groups.
B. Coronavirus infection is mild in children.
C. Older person and persons with pre-existing medical
conditions are at high risk to develop serious illness.
D. All the above are correct,
Ans. D
Explanation: COVID-19 occurs in all age groups. But
according to AIMS the infection of coronavirus is mild
in children. Persons are at risk who are old and person
suffering from some medical conditions like high blood
pressure, cancer, lung disease, diabetes, heart disease.
What other viruses belong to the
coronavirus family?
• SARS and influenza
• SARS and MERS
• SARS and HIV
Mild Symptoms of Novel coronavirus
are:
• A. Fever
B. Cough
C. Shortness of breath
D. All the above
Ans. D
Explanation: People infected with novel
coronavirus or 2019-nCoV reported mild
symptoms namely fever, cough, and shortness of
breath. Whereas other common symptoms may
include a runny nose, headache, sore throat, a
general feeling of unwellness, etc.
What are the precautions that need
to be taken to protect from the
coronavirus?
• A. Cover your nose and mouth when sneezing.
B. Add more garlic into your diet.
C. Visit your doctor for antibiotics treatment
D. Wash your hands after every hour.
Ans. A
Explanation: According to WHO, a person can
take precautions by covering the nose and mouth
while sneezing via tissue or an elbow. Then,
immediately throw the tissue into a closed
dustbin.
A vaccine stimulates your immune
system to produce antibodies, like it
would if you were exposed to the
virus.
• True
• False
Which of the following diseases are
related to coronavirus?
• A. MERS
B. SARS
C. Both A and B
D. Neither A nor B
Ans. C
Explanation: Coronavirus may cause illness from
the common cold to more other serious diseases
like Middle East Respiratory Syndrome (MERS-
CoV) and Severe Acute Respiratory Syndrome
(SARS-CoV).
• What happens to a person suffering from COVID-19?
A. Around 80% of the people will require no treatment as
such and will recover on their own.
B. Around <20% or a small proportion may need
hospitalisation.
C. A very small proportion basically suffering from chronic
illness may need admission in an Intensive Care Unit (ICU).
D. All the above are correct
Ans. D
Explanation: A person who develops COVID-19: The
majority of the people (80%) does not require treatment
and will recover on their own, a small proportion (<20%)
may need hospitalisation and a very small proportion who
are underlying chronic illness may need to admit in an ICU.
There are currently vaccines for the
following coronaviruses:
• SARS
• MERS
• SARS and MERS
• None of the above
How many vaccine candidates for
COVID-19 have been proposed?
• 25 %
• 50%
• 100%
• More than 200 %
The virus is mutating rapidly.
• True
• False:
World Health Organisation on 11 February, 2020 announced an
official name for the disease that is causing the 2019 novel
coronavirus outbreak? What is the new name of the disease?
• A. COVID-19
B. COVn-19
C. COnV-20
D. COnVID-19
Ans. A
Explanation: WHO named the disease that is
caused by the novel coronavirus as COVID-
How does weather seem to affect the
novel coronavirus?
• The virus can’t survive in hot, humid climates.
• Cold temperatures can kill the virus.
• It is not yet known.
Currently, which group has had more
severe effects of COVID-19?
• Men
• Women
• Children
• Oldage
What is quarantine ?
• Quarantine is used for anyone who is a
contact of someone infected with the SARS-
CoV-2 virus, which causes COVID-19, whether
the infected person has symptoms or not.
• For COVID-19, this means staying in the facility
or at home for 14 days.
What is isolation ?
• Isolation is used for people with COVID-19
symptoms or who have tested positive for the
virus. Being in isolation means being
separated from other people, ideally in a
medically facility where you can receive
clinical care. Minimum 10 days plus 3 days
What are the complications?
• Complications leading to death may include
respiratory failure, acute respiratory distress
syndrome (ARDS), sepsis and septic shock,
thromboembolism, and/or multiorgan failure,
including injury of the heart, liver or kidneys.
• How many countries, areas, or territories are
suffering from novel coronavirus outbreaks in
the World?
A. More than 50
B. More than 100
C. More than 150
D. More than 200
Ans. D
Explanation: According to WHO, around 216
countries, areas or territories are suffering from
novel coronavirus or COVID-19 outbreak in the
world till 11 June, 2020.
• Thailand announced that it has proceeded to test it's
novel coronavirus vaccine on which animal/bird?
A. Monkeys
B. Lizards
C. Hens
D. Kites
Ans. A
Explanation: After seeing positive results on mice now
Thailand announced that it has proceeded to test its
novel coronavirus vaccine on monkeys. The vaccine
uses messenger RNA (mRNA) technology to weaken
the strain of the virus and produce antigens to fight
with the virus from the root.
• In a study, which cells are found in COVID-19
patients 'bode well' for long-term immunity?
A. P-cell
B. D-Cell
C. T-Cell
D. Endothelial Cells
Ans. C
Explanation: T cells are known as immune
warriors help us fight some viruses, but their
importance for battling SARS-CoV-2, the virus
that causes COVID-19, has been unclear. Research
is going on and maybe it can be fruitful.
COVID-19 has currently been detected
on all seven continents.
• True
• False
• When the arogya set up formed in India?
• A.25 march 2020
• B.1 April 2020
• C.2April 2020
• D.10 April 2020
• Name a clinical trial in which blood is transfused
from recovered COVID-19 patients to a
coronavirus patient who is in critical condition?
A. Plasma Therapy
B. Solidarity
C. Remdesivir
D. Hydroxychloroquine
Ans. A
Explanation: Plasma Therapy or Convalescent
Plasma Therapy is a clinical trial in which blood is
transfused from recovered COVID-19 patients to
a coronavirus patient who is in critical condition.
Name the vaccine that is jointly developed by the German
company BioNTech and US pharma giant Pfizer for COVID-
19?
A. BNT162
B. PICOVACC
C. Both A and B
D. Neither A nor B
Ans. A
Explanation: BNT162 is jointly developed by the German
company BioNTech and US pharma giant Pfizer. It is a group
of four potential vaccines based on the messenger RNA or
mRNA, concept. On the other hand, PICOVACC is an
inactivated vaccine developed by the private biopharma
company Sinovac. These vaccines are in clinical trial phases.
• Which of the following statement is/are correct about
Favipiravir?
A. Favipiravir is an antiviral COVID-19 drug.
B. Glenmark Pharmaceuticals under the brand name
FabiFlu has launched an antiviral drug Favipiravir.
C. It is India's first COVID-19 drug launched, priced at Rs 103
per tablet.
D. All the above are correct
Ans. D
Explanation: Favipiravir is an antiviral COVID-19 drug.
Glenmark Pharmaceuticals under the brand name FabiFlu
has launched an antiviral drug Favipiravir. It is India's first
COVID-19 drug launched, priced at Rs 103 per tablet.
• In India, when did the second phase of COVID-19
vaccination start?
• A. December 2020
B. January 2021
C. February 2021
D. March 2021
• Ans. D
• Explanation: On 1 March, 2021, the second phase of
vaccination started in India that allows all Indians
above the age of 60 and Indians between the age of 45
and 59 with comorbidities to be vaccinated.
• Which of the following are the causes of Yellow Fungus
infection?
• 1. Poor hygiene
2. Moisture and heat
3. Contaminated food
4. Overuse of steroids
• A. 1 and 4
B. 2, 3 and 4
C. 1, 2 and 3
D. 1, 2, 3 and 4
• Ans. D
• Explanation:
• The causes of Yellow Fungus infection are poor
hygiene, moisture and heat, contaminated food and
overuse of steroids.
When the vaccine program started ?
• The first mass vaccination programme started in early
December 2020 and the number of vaccination doses
administered is updated on a daily basis .
• The Pfizer/BioNtech Comirnaty vaccine was listed for
WHO Emergency Use Listing (EUL) on 31 December
2020.
• The SII/Covishield and AstraZeneca/AZD1222 vaccines
(developed by AstraZeneca/Oxford and manufactured
by the Serum Institute of India and SK Bio respectively)
were given EUL on 16 February.
• The Janssen/Ad26.COV 2.S developed by
Johnson & Johnson, was listed for EUL on 12
March 2021.
• The Moderna COVID-19 vaccine (mRNA 1273)
was listed for EUL on 30 April 2021 and the
Sinopharm COVID-19 vaccine was listed for
EUL on 7 May 2021.
Dose of vaccine?
• One dose
• Two dose
• Three dose
• Booster dose
Route and frequency of covid vaccine?
• SC/ 30 days
• SC/28 days
• SC/3 month
• SC/14 days
THANK YOU
• Give your valuble likes
• Comments, share,

More Related Content

What's hot (20)

EPIDEMIOLOGY OF TUBERCULOSIS
EPIDEMIOLOGY OF TUBERCULOSISEPIDEMIOLOGY OF TUBERCULOSIS
EPIDEMIOLOGY OF TUBERCULOSIS
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Influenza
InfluenzaInfluenza
Influenza
 
Tb TUBERCULOSIS
Tb TUBERCULOSISTb TUBERCULOSIS
Tb TUBERCULOSIS
 
Cholera
CholeraCholera
Cholera
 
Measles (rubeola)
Measles (rubeola)Measles (rubeola)
Measles (rubeola)
 
Influenza
InfluenzaInfluenza
Influenza
 
Rickettsial diseases
Rickettsial diseasesRickettsial diseases
Rickettsial diseases
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Epidemiology & prevention of tuberculosis
Epidemiology & prevention of tuberculosisEpidemiology & prevention of tuberculosis
Epidemiology & prevention of tuberculosis
 
Pandemic covid 19 power point templates
Pandemic covid 19 power point templatesPandemic covid 19 power point templates
Pandemic covid 19 power point templates
 
Covid 19 Corona virus
Covid 19  Corona virus Covid 19  Corona virus
Covid 19 Corona virus
 
Common cold
Common coldCommon cold
Common cold
 
Covid 19
Covid 19Covid 19
Covid 19
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Tuberculosis ppt
Tuberculosis pptTuberculosis ppt
Tuberculosis ppt
 
Chikungunya fever
Chikungunya feverChikungunya fever
Chikungunya fever
 
Filariasis
FilariasisFilariasis
Filariasis
 

Similar to Corona virus related MCQ

Corona Virus Disease - Covid 19 (nCorona Virus-2019) Update
Corona Virus Disease - Covid 19 (nCorona Virus-2019) UpdateCorona Virus Disease - Covid 19 (nCorona Virus-2019) Update
Corona Virus Disease - Covid 19 (nCorona Virus-2019) UpdateDr. Annasaheb Dhumale
 
Case study of covid 19.pdf by HARSHITHA BHARADWAJ
Case study of covid 19.pdf by HARSHITHA BHARADWAJCase study of covid 19.pdf by HARSHITHA BHARADWAJ
Case study of covid 19.pdf by HARSHITHA BHARADWAJprem kamal
 
Presentation on covid 19
Presentation on covid 19Presentation on covid 19
Presentation on covid 19Vipin Shukla
 
covid-19 corona virus
covid-19 corona virus covid-19 corona virus
covid-19 corona virus tulu2015
 
CORONA VIRUS & it’s effect on daily life
CORONA VIRUS & it’s effect on  daily lifeCORONA VIRUS & it’s effect on  daily life
CORONA VIRUS & it’s effect on daily lifeDanao Maibam
 
Coronavirus here's-what-you-need-to-know
Coronavirus here's-what-you-need-to-knowCoronavirus here's-what-you-need-to-know
Coronavirus here's-what-you-need-to-knowSITIAISHAHRAMLI1
 
Covid 19 Awareness Series (Part 4)
Covid 19 Awareness Series (Part 4)Covid 19 Awareness Series (Part 4)
Covid 19 Awareness Series (Part 4)SANI SINGH
 
COVID-19: CAUSES, SYMPTOMS AND BASIC PREVENTIVE MEASURES
COVID-19: CAUSES, SYMPTOMS AND BASIC PREVENTIVE MEASURESCOVID-19: CAUSES, SYMPTOMS AND BASIC PREVENTIVE MEASURES
COVID-19: CAUSES, SYMPTOMS AND BASIC PREVENTIVE MEASURESDrShiv Shankar
 
Covid 19 epidemiology
Covid 19 epidemiologyCovid 19 epidemiology
Covid 19 epidemiologyABHISHEK
 
Corona virus 2020 what need know
Corona virus 2020 what need knowCorona virus 2020 what need know
Corona virus 2020 what need knowRomasTamosevicius
 
Coronavirus FAQ : Covid-19
Coronavirus FAQ : Covid-19Coronavirus FAQ : Covid-19
Coronavirus FAQ : Covid-19Education
 
COVID-19 Infection Prevention and Control (IPC)
COVID-19 Infection Prevention and Control (IPC)COVID-19 Infection Prevention and Control (IPC)
COVID-19 Infection Prevention and Control (IPC)Updesh Yadav
 
#Covid19: Information guide for general Public.
#Covid19: Information guide for general Public.#Covid19: Information guide for general Public.
#Covid19: Information guide for general Public.MADHUR VERMA
 
2019 ncovarifa-200126133128
2019 ncovarifa-2001261331282019 ncovarifa-200126133128
2019 ncovarifa-200126133128Dr.Arifa Akram
 

Similar to Corona virus related MCQ (20)

Corona Virus Disease - Covid 19 (nCorona Virus-2019) Update
Corona Virus Disease - Covid 19 (nCorona Virus-2019) UpdateCorona Virus Disease - Covid 19 (nCorona Virus-2019) Update
Corona Virus Disease - Covid 19 (nCorona Virus-2019) Update
 
Covid 19 kbc
Covid 19 kbcCovid 19 kbc
Covid 19 kbc
 
Coronavirus
CoronavirusCoronavirus
Coronavirus
 
Case study of covid 19.pdf by HARSHITHA BHARADWAJ
Case study of covid 19.pdf by HARSHITHA BHARADWAJCase study of covid 19.pdf by HARSHITHA BHARADWAJ
Case study of covid 19.pdf by HARSHITHA BHARADWAJ
 
Corona
CoronaCorona
Corona
 
Coronavirus (COVID-19)
Coronavirus (COVID-19) Coronavirus (COVID-19)
Coronavirus (COVID-19)
 
Presentation on covid 19
Presentation on covid 19Presentation on covid 19
Presentation on covid 19
 
covid-19 corona virus
covid-19 corona virus covid-19 corona virus
covid-19 corona virus
 
CORONA VIRUS & it’s effect on daily life
CORONA VIRUS & it’s effect on  daily lifeCORONA VIRUS & it’s effect on  daily life
CORONA VIRUS & it’s effect on daily life
 
Coronavirus here's-what-you-need-to-know
Coronavirus here's-what-you-need-to-knowCoronavirus here's-what-you-need-to-know
Coronavirus here's-what-you-need-to-know
 
Covid 19 Awareness Series (Part 4)
Covid 19 Awareness Series (Part 4)Covid 19 Awareness Series (Part 4)
Covid 19 Awareness Series (Part 4)
 
COVID-19: CAUSES, SYMPTOMS AND BASIC PREVENTIVE MEASURES
COVID-19: CAUSES, SYMPTOMS AND BASIC PREVENTIVE MEASURESCOVID-19: CAUSES, SYMPTOMS AND BASIC PREVENTIVE MEASURES
COVID-19: CAUSES, SYMPTOMS AND BASIC PREVENTIVE MEASURES
 
Covid 19 epidemiology
Covid 19 epidemiologyCovid 19 epidemiology
Covid 19 epidemiology
 
Corona virus 2020 what need know
Corona virus 2020 what need knowCorona virus 2020 what need know
Corona virus 2020 what need know
 
Coronavirus FAQ : Covid-19
Coronavirus FAQ : Covid-19Coronavirus FAQ : Covid-19
Coronavirus FAQ : Covid-19
 
COVID-19 Infection Prevention and Control (IPC)
COVID-19 Infection Prevention and Control (IPC)COVID-19 Infection Prevention and Control (IPC)
COVID-19 Infection Prevention and Control (IPC)
 
#Covid19: Information guide for general Public.
#Covid19: Information guide for general Public.#Covid19: Information guide for general Public.
#Covid19: Information guide for general Public.
 
Coronavirus diseases
Coronavirus diseasesCoronavirus diseases
Coronavirus diseases
 
2019 ncovarifa-200126133128
2019 ncovarifa-2001261331282019 ncovarifa-200126133128
2019 ncovarifa-200126133128
 
Covid 19
Covid 19 Covid 19
Covid 19
 

More from anjalatchi

Unit –IV Nursing Management oragnization M,Sc II year 2023.pptx
Unit –IV Nursing Management oragnization M,Sc II year 2023.pptxUnit –IV Nursing Management oragnization M,Sc II year 2023.pptx
Unit –IV Nursing Management oragnization M,Sc II year 2023.pptxanjalatchi
 
INTERNATIONAL AND NATIONAL NURSES WEEK SPEECH 12.5.23.pptx
INTERNATIONAL AND NATIONAL NURSES WEEK SPEECH 12.5.23.pptxINTERNATIONAL AND NATIONAL NURSES WEEK SPEECH 12.5.23.pptx
INTERNATIONAL AND NATIONAL NURSES WEEK SPEECH 12.5.23.pptxanjalatchi
 
VOTE OF THANKS FOR NURSES DAY WEEK CELEBRATION 8.5.23.pptx
VOTE OF THANKS FOR NURSES DAY WEEK CELEBRATION 8.5.23.pptxVOTE OF THANKS FOR NURSES DAY WEEK CELEBRATION 8.5.23.pptx
VOTE OF THANKS FOR NURSES DAY WEEK CELEBRATION 8.5.23.pptxanjalatchi
 
Unit -III Planning and control M.sc II year.pptx
Unit -III Planning and control M.sc II year.pptxUnit -III Planning and control M.sc II year.pptx
Unit -III Planning and control M.sc II year.pptxanjalatchi
 
ANTI TOBACCO DAY essay.docx
ANTI TOBACCO DAY essay.docxANTI TOBACCO DAY essay.docx
ANTI TOBACCO DAY essay.docxanjalatchi
 
PBBSC Nursing Syllabus 2015.docx
PBBSC Nursing Syllabus 2015.docxPBBSC Nursing Syllabus 2015.docx
PBBSC Nursing Syllabus 2015.docxanjalatchi
 
course Plan For CHN P.B.Sc.docx
course Plan For CHN P.B.Sc.docxcourse Plan For CHN P.B.Sc.docx
course Plan For CHN P.B.Sc.docxanjalatchi
 
LIST OF CHAPTER FOR P.B.SC CHN BOOK.docx
LIST OF CHAPTER FOR P.B.SC CHN BOOK.docxLIST OF CHAPTER FOR P.B.SC CHN BOOK.docx
LIST OF CHAPTER FOR P.B.SC CHN BOOK.docxanjalatchi
 
M.SC (N) synopsis format.docx
M.SC (N) synopsis format.docxM.SC (N) synopsis format.docx
M.SC (N) synopsis format.docxanjalatchi
 
BMWM 2019 GUIDELINESS.pdf
BMWM 2019 GUIDELINESS.pdfBMWM 2019 GUIDELINESS.pdf
BMWM 2019 GUIDELINESS.pdfanjalatchi
 
Daily ADR Reporting Form April 2023.docx
Daily ADR Reporting Form April 2023.docxDaily ADR Reporting Form April 2023.docx
Daily ADR Reporting Form April 2023.docxanjalatchi
 
TRAINNING TOPIC FOR ANNUAL SCHEDULE.docx
TRAINNING TOPIC FOR ANNUAL SCHEDULE.docxTRAINNING TOPIC FOR ANNUAL SCHEDULE.docx
TRAINNING TOPIC FOR ANNUAL SCHEDULE.docxanjalatchi
 
TRAINING SIGN FINAL RECORD.docx
TRAINING SIGN FINAL RECORD.docxTRAINING SIGN FINAL RECORD.docx
TRAINING SIGN FINAL RECORD.docxanjalatchi
 
slogan competation poster 2.5.23.docx
slogan competation poster 2.5.23.docxslogan competation poster 2.5.23.docx
slogan competation poster 2.5.23.docxanjalatchi
 
Screening TB format.docx
Screening TB  format.docxScreening TB  format.docx
Screening TB format.docxanjalatchi
 
report of world glucoma day 2023.docx
report of world glucoma day 2023.docxreport of world glucoma day 2023.docx
report of world glucoma day 2023.docxanjalatchi
 
REPORT ON WORLD AIDS DAY 2022 CELEBRATION AT ELMCH.docx
REPORT ON WORLD AIDS DAY 2022 CELEBRATION AT ELMCH.docxREPORT ON WORLD AIDS DAY 2022 CELEBRATION AT ELMCH.docx
REPORT ON WORLD AIDS DAY 2022 CELEBRATION AT ELMCH.docxanjalatchi
 
REPORT OF WORLD TUBERCLOSIS DAY 2023.docx
REPORT  OF WORLD TUBERCLOSIS DAY 2023.docxREPORT  OF WORLD TUBERCLOSIS DAY 2023.docx
REPORT OF WORLD TUBERCLOSIS DAY 2023.docxanjalatchi
 
NURSING OFFICER EXAM ON MCQ MODEL PAPER.docx
NURSING OFFICER EXAM ON  MCQ MODEL PAPER.docxNURSING OFFICER EXAM ON  MCQ MODEL PAPER.docx
NURSING OFFICER EXAM ON MCQ MODEL PAPER.docxanjalatchi
 
International nurses week celebration 13.5 PPT.pptx
International nurses week celebration 13.5 PPT.pptxInternational nurses week celebration 13.5 PPT.pptx
International nurses week celebration 13.5 PPT.pptxanjalatchi
 

More from anjalatchi (20)

Unit –IV Nursing Management oragnization M,Sc II year 2023.pptx
Unit –IV Nursing Management oragnization M,Sc II year 2023.pptxUnit –IV Nursing Management oragnization M,Sc II year 2023.pptx
Unit –IV Nursing Management oragnization M,Sc II year 2023.pptx
 
INTERNATIONAL AND NATIONAL NURSES WEEK SPEECH 12.5.23.pptx
INTERNATIONAL AND NATIONAL NURSES WEEK SPEECH 12.5.23.pptxINTERNATIONAL AND NATIONAL NURSES WEEK SPEECH 12.5.23.pptx
INTERNATIONAL AND NATIONAL NURSES WEEK SPEECH 12.5.23.pptx
 
VOTE OF THANKS FOR NURSES DAY WEEK CELEBRATION 8.5.23.pptx
VOTE OF THANKS FOR NURSES DAY WEEK CELEBRATION 8.5.23.pptxVOTE OF THANKS FOR NURSES DAY WEEK CELEBRATION 8.5.23.pptx
VOTE OF THANKS FOR NURSES DAY WEEK CELEBRATION 8.5.23.pptx
 
Unit -III Planning and control M.sc II year.pptx
Unit -III Planning and control M.sc II year.pptxUnit -III Planning and control M.sc II year.pptx
Unit -III Planning and control M.sc II year.pptx
 
ANTI TOBACCO DAY essay.docx
ANTI TOBACCO DAY essay.docxANTI TOBACCO DAY essay.docx
ANTI TOBACCO DAY essay.docx
 
PBBSC Nursing Syllabus 2015.docx
PBBSC Nursing Syllabus 2015.docxPBBSC Nursing Syllabus 2015.docx
PBBSC Nursing Syllabus 2015.docx
 
course Plan For CHN P.B.Sc.docx
course Plan For CHN P.B.Sc.docxcourse Plan For CHN P.B.Sc.docx
course Plan For CHN P.B.Sc.docx
 
LIST OF CHAPTER FOR P.B.SC CHN BOOK.docx
LIST OF CHAPTER FOR P.B.SC CHN BOOK.docxLIST OF CHAPTER FOR P.B.SC CHN BOOK.docx
LIST OF CHAPTER FOR P.B.SC CHN BOOK.docx
 
M.SC (N) synopsis format.docx
M.SC (N) synopsis format.docxM.SC (N) synopsis format.docx
M.SC (N) synopsis format.docx
 
BMWM 2019 GUIDELINESS.pdf
BMWM 2019 GUIDELINESS.pdfBMWM 2019 GUIDELINESS.pdf
BMWM 2019 GUIDELINESS.pdf
 
Daily ADR Reporting Form April 2023.docx
Daily ADR Reporting Form April 2023.docxDaily ADR Reporting Form April 2023.docx
Daily ADR Reporting Form April 2023.docx
 
TRAINNING TOPIC FOR ANNUAL SCHEDULE.docx
TRAINNING TOPIC FOR ANNUAL SCHEDULE.docxTRAINNING TOPIC FOR ANNUAL SCHEDULE.docx
TRAINNING TOPIC FOR ANNUAL SCHEDULE.docx
 
TRAINING SIGN FINAL RECORD.docx
TRAINING SIGN FINAL RECORD.docxTRAINING SIGN FINAL RECORD.docx
TRAINING SIGN FINAL RECORD.docx
 
slogan competation poster 2.5.23.docx
slogan competation poster 2.5.23.docxslogan competation poster 2.5.23.docx
slogan competation poster 2.5.23.docx
 
Screening TB format.docx
Screening TB  format.docxScreening TB  format.docx
Screening TB format.docx
 
report of world glucoma day 2023.docx
report of world glucoma day 2023.docxreport of world glucoma day 2023.docx
report of world glucoma day 2023.docx
 
REPORT ON WORLD AIDS DAY 2022 CELEBRATION AT ELMCH.docx
REPORT ON WORLD AIDS DAY 2022 CELEBRATION AT ELMCH.docxREPORT ON WORLD AIDS DAY 2022 CELEBRATION AT ELMCH.docx
REPORT ON WORLD AIDS DAY 2022 CELEBRATION AT ELMCH.docx
 
REPORT OF WORLD TUBERCLOSIS DAY 2023.docx
REPORT  OF WORLD TUBERCLOSIS DAY 2023.docxREPORT  OF WORLD TUBERCLOSIS DAY 2023.docx
REPORT OF WORLD TUBERCLOSIS DAY 2023.docx
 
NURSING OFFICER EXAM ON MCQ MODEL PAPER.docx
NURSING OFFICER EXAM ON  MCQ MODEL PAPER.docxNURSING OFFICER EXAM ON  MCQ MODEL PAPER.docx
NURSING OFFICER EXAM ON MCQ MODEL PAPER.docx
 
International nurses week celebration 13.5 PPT.pptx
International nurses week celebration 13.5 PPT.pptxInternational nurses week celebration 13.5 PPT.pptx
International nurses week celebration 13.5 PPT.pptx
 

Recently uploaded

办理多伦多大学毕业证成绩单|购买加拿大UTSG文凭证书
办理多伦多大学毕业证成绩单|购买加拿大UTSG文凭证书办理多伦多大学毕业证成绩单|购买加拿大UTSG文凭证书
办理多伦多大学毕业证成绩单|购买加拿大UTSG文凭证书zdzoqco
 
IP addressing and IPv6, presented by Paul Wilson at IETF 119
IP addressing and IPv6, presented by Paul Wilson at IETF 119IP addressing and IPv6, presented by Paul Wilson at IETF 119
IP addressing and IPv6, presented by Paul Wilson at IETF 119APNIC
 
Top 10 Interactive Website Design Trends in 2024.pptx
Top 10 Interactive Website Design Trends in 2024.pptxTop 10 Interactive Website Design Trends in 2024.pptx
Top 10 Interactive Website Design Trends in 2024.pptxDyna Gilbert
 
TRENDS Enabling and inhibiting dimensions.pptx
TRENDS Enabling and inhibiting dimensions.pptxTRENDS Enabling and inhibiting dimensions.pptx
TRENDS Enabling and inhibiting dimensions.pptxAndrieCagasanAkio
 
Unidad 4 – Redes de ordenadores (en inglés).pptx
Unidad 4 – Redes de ordenadores (en inglés).pptxUnidad 4 – Redes de ordenadores (en inglés).pptx
Unidad 4 – Redes de ordenadores (en inglés).pptxmibuzondetrabajo
 
『澳洲文凭』买詹姆士库克大学毕业证书成绩单办理澳洲JCU文凭学位证书
『澳洲文凭』买詹姆士库克大学毕业证书成绩单办理澳洲JCU文凭学位证书『澳洲文凭』买詹姆士库克大学毕业证书成绩单办理澳洲JCU文凭学位证书
『澳洲文凭』买詹姆士库克大学毕业证书成绩单办理澳洲JCU文凭学位证书rnrncn29
 
『澳洲文凭』买拉筹伯大学毕业证书成绩单办理澳洲LTU文凭学位证书
『澳洲文凭』买拉筹伯大学毕业证书成绩单办理澳洲LTU文凭学位证书『澳洲文凭』买拉筹伯大学毕业证书成绩单办理澳洲LTU文凭学位证书
『澳洲文凭』买拉筹伯大学毕业证书成绩单办理澳洲LTU文凭学位证书rnrncn29
 
Film cover research (1).pptxsdasdasdasdasdasa
Film cover research (1).pptxsdasdasdasdasdasaFilm cover research (1).pptxsdasdasdasdasdasa
Film cover research (1).pptxsdasdasdasdasdasa494f574xmv
 
Company Snapshot Theme for Business by Slidesgo.pptx
Company Snapshot Theme for Business by Slidesgo.pptxCompany Snapshot Theme for Business by Slidesgo.pptx
Company Snapshot Theme for Business by Slidesgo.pptxMario
 
ETHICAL HACKING dddddddddddddddfnandni.pptx
ETHICAL HACKING dddddddddddddddfnandni.pptxETHICAL HACKING dddddddddddddddfnandni.pptx
ETHICAL HACKING dddddddddddddddfnandni.pptxNIMMANAGANTI RAMAKRISHNA
 
SCM Symposium PPT Format Customer loyalty is predi
SCM Symposium PPT Format Customer loyalty is prediSCM Symposium PPT Format Customer loyalty is predi
SCM Symposium PPT Format Customer loyalty is predieusebiomeyer
 

Recently uploaded (11)

办理多伦多大学毕业证成绩单|购买加拿大UTSG文凭证书
办理多伦多大学毕业证成绩单|购买加拿大UTSG文凭证书办理多伦多大学毕业证成绩单|购买加拿大UTSG文凭证书
办理多伦多大学毕业证成绩单|购买加拿大UTSG文凭证书
 
IP addressing and IPv6, presented by Paul Wilson at IETF 119
IP addressing and IPv6, presented by Paul Wilson at IETF 119IP addressing and IPv6, presented by Paul Wilson at IETF 119
IP addressing and IPv6, presented by Paul Wilson at IETF 119
 
Top 10 Interactive Website Design Trends in 2024.pptx
Top 10 Interactive Website Design Trends in 2024.pptxTop 10 Interactive Website Design Trends in 2024.pptx
Top 10 Interactive Website Design Trends in 2024.pptx
 
TRENDS Enabling and inhibiting dimensions.pptx
TRENDS Enabling and inhibiting dimensions.pptxTRENDS Enabling and inhibiting dimensions.pptx
TRENDS Enabling and inhibiting dimensions.pptx
 
Unidad 4 – Redes de ordenadores (en inglés).pptx
Unidad 4 – Redes de ordenadores (en inglés).pptxUnidad 4 – Redes de ordenadores (en inglés).pptx
Unidad 4 – Redes de ordenadores (en inglés).pptx
 
『澳洲文凭』买詹姆士库克大学毕业证书成绩单办理澳洲JCU文凭学位证书
『澳洲文凭』买詹姆士库克大学毕业证书成绩单办理澳洲JCU文凭学位证书『澳洲文凭』买詹姆士库克大学毕业证书成绩单办理澳洲JCU文凭学位证书
『澳洲文凭』买詹姆士库克大学毕业证书成绩单办理澳洲JCU文凭学位证书
 
『澳洲文凭』买拉筹伯大学毕业证书成绩单办理澳洲LTU文凭学位证书
『澳洲文凭』买拉筹伯大学毕业证书成绩单办理澳洲LTU文凭学位证书『澳洲文凭』买拉筹伯大学毕业证书成绩单办理澳洲LTU文凭学位证书
『澳洲文凭』买拉筹伯大学毕业证书成绩单办理澳洲LTU文凭学位证书
 
Film cover research (1).pptxsdasdasdasdasdasa
Film cover research (1).pptxsdasdasdasdasdasaFilm cover research (1).pptxsdasdasdasdasdasa
Film cover research (1).pptxsdasdasdasdasdasa
 
Company Snapshot Theme for Business by Slidesgo.pptx
Company Snapshot Theme for Business by Slidesgo.pptxCompany Snapshot Theme for Business by Slidesgo.pptx
Company Snapshot Theme for Business by Slidesgo.pptx
 
ETHICAL HACKING dddddddddddddddfnandni.pptx
ETHICAL HACKING dddddddddddddddfnandni.pptxETHICAL HACKING dddddddddddddddfnandni.pptx
ETHICAL HACKING dddddddddddddddfnandni.pptx
 
SCM Symposium PPT Format Customer loyalty is predi
SCM Symposium PPT Format Customer loyalty is prediSCM Symposium PPT Format Customer loyalty is predi
SCM Symposium PPT Format Customer loyalty is predi
 

Corona virus related MCQ

  • 1. Corona virus related MCQ for examination purpose Dr. Anjalatchi Muthukumaran
  • 2. MCQ/objective type /true/false The first case of corona-virus found in ---- a. Beijing b. Thailand c. Wuhan, china d. Italy
  • 3. • The first case of corona found outside of china? • A. Italy • B. America • C. Thailand • D. Spain
  • 4. When the first case of corona seen in India? • A. 20 January 2020 • B.30 January2020 kerala • C.1 February 2020 • D.25 January 2020 • Second case seen in –alappuzu kerala • Third case seen in –kasargodu kerala
  • 5. When WHO declared officially declared covid-19 became pandemic? • A. 9 January 2020 • B.13 January 2020 • C.11 march 2020 • D.30 January 2020
  • 6. When was COVID-19 first identified? • On 31 December 2019, WHO was informed of cases of pneumonia of unknown cause in Wuhan City, China. • A novel coronavirus was identified as the cause by Chinese authorities on 7 January 2020 and was temporarily named “2019- nCoV”.
  • 7. • Which organs are most affected by COVID-19? • The lungs are the organs most affected by COVID-19 because the virus accesses host cells via the receptor for the enzyme angiotensin-converting enzyme 2 (ACE2), which is most abundant on the surface of type II alveolar cells of the lungs.
  • 8. • When was the official name of SARS-CoV-2 announced? • On 11 February 2020, the International Committee on Taxonomy of Viruses adopted the official name "severe acute respiratory syndrome coronavirus 2" (SARS-CoV-2).
  • 9. • What is Coronavirus? A. It is a large family of viruses. B. It belongs to the family of Nidovirus. C. Both A and B are correct D. Only A is correct. Ans. C Explanation: Coronaviruses are a large family of viruses and belong to the Nidovirus family or Nidovirales order, which includes Coronaviridae, Arteriviridae, and Roniviridae families.
  • 10. What does COVID-19 stand for? • It's a term for Coronavirus Disease 19, because it's the 19th strain of coronavirus discovered. • It's a term that stands for Coronavirus Disease 2019, the year it was first identified.
  • 11. Janta Curfew declared in India? • 21 march 2020 • 22 march 2020 • 23 march 2020 • 24 march 2020 • First lockdown Held in – 24 march 2020 • Second lockdown held in -15 April to 3 may 2020
  • 12. Which area consider as a Hot Pots Area of corona? • Red zones • Yellow zones • Orange zones • Green zones
  • 13. Which are the common diseases related to corona virus ? • A. SARS • B.MERS • C.Both • D. None
  • 14. Incubation period of corona virus? • A. 2-14days • B.3-7 days • C. 2-21 days • D. 2-28days
  • 15. When the Indian Air force shower the flower on corona warriors? • 22 march 2020 • 5 April 2020 • 3 may 2020 • 3 June 2020
  • 16. • Which type of disinfectant effective on corona virus for sanitize purpose? • 40% alcohol • Dettol 40 % • 70% methylspirit • 60 % ethonol
  • 17. Which type of disinfectant useful in surface cleaning purpose on covid -19 exposure? • A. Phenol • B. Sodium hypochlorite • C.Glutaldehyde • D. Chlorohexidine
  • 18. • The most common test to detect the corona virus? • A. patchy test • B. antibody test • C. RT-PCR • D. both b&c
  • 19. The most common symptoms of COVID-19 are • Fever • Dry cough • Fatigue
  • 20. Other symptoms that are less common and may affect some patients include: • Loss of taste or smell, • Nasal congestion, • Conjunctivitis (also known as red eyes) • Sore throat, • Headache, • Muscle or joint pain, • Different types of skin rash, • Nausea or vomiting, • Diarrhea, • Chills or dizziness.
  • 21. Symptoms of severe COVID‐19 disease include: • Shortness of breath, • Loss of appetite, • Confusion, • Persistent pain or pressure in the chest, • High temperature (above 38 °C).
  • 22. Which of the following statements regarding Isolation during COVID-19 is/are correct? 1. It is used for people suffering from COVID-19 symptoms or who have tested positive for the virus. 2. In isolation means being separated from other people, mainly in a medical facility where you can receive clinical care. A. Only 1 B. Only 2 C. Both 1 and 2 D. Neither 1 nor 2 Ans. C • Explanation: Isolation is used for those people who have COVID-19 symptoms or who have tested positive. In isolation means being separated from other people, mainly in a medical facility where you can receive clinical care. As per WHO, if any person has symptoms then he or she should remain in isolation for at least 10 days plus an additional 3 days without symptoms. If a person is infected and does not develop symptoms then he or she should remain in isolation for 10 days from the time he or she test positive.
  • 23. • Consider the following statements. • 1. When a virus does not change is called a mutation. 2. A virus with one or more new mutations is known as a “variant” of the original virus. Which of the following statements is/are correct? A. Only 1 B. Only 2 C. Both 1 and 2 D. Neither 1 nor 2 Ans. B Explanation: When a virus replicates makes copies of itself sometimes changes a little bit which is normal for a virus. These changes are known as mutations and a virus with one or more new mutations is known as a "variant" of the original virus.
  • 24. How does Coronavirus transmit? A. When a person sneezes or coughs, droplets spread in the air or fall on the ground and nearby surfaces. B. If another person is nearby and inhales the droplets or touches these surfaces and further touches his face, eyes, or mouth, he or she can get an infection. C. If the distance is less than 1 meter from the infected person. D. D. All the above are correct. Ans. D Explanation: Coronavirus (COVID-19) transmits through the above-mentioned options.
  • 25. The first case of novel coronavirus was identified in ..... A. Beijing B. Shanghai C. C. Wuhan, Hubei D. D. Tianjin E. Ans. C Explanation: The first case of novel coronavirus was identified in Wuhan, Hubei Province, China.
  • 26. From where coronavirus got its name? • A. Due to their crown-like projections. B. Due to their leaf-like projections. C. Due to their surface structure of bricks. D. None of the above
  • 27. In which age group the COVID-19 spreads? A. COVID-19 occurs in all age groups. B. Coronavirus infection is mild in children. C. Older person and persons with pre-existing medical conditions are at high risk to develop serious illness. D. All the above are correct, Ans. D Explanation: COVID-19 occurs in all age groups. But according to AIMS the infection of coronavirus is mild in children. Persons are at risk who are old and person suffering from some medical conditions like high blood pressure, cancer, lung disease, diabetes, heart disease.
  • 28. What other viruses belong to the coronavirus family? • SARS and influenza • SARS and MERS • SARS and HIV
  • 29. Mild Symptoms of Novel coronavirus are: • A. Fever B. Cough C. Shortness of breath D. All the above Ans. D Explanation: People infected with novel coronavirus or 2019-nCoV reported mild symptoms namely fever, cough, and shortness of breath. Whereas other common symptoms may include a runny nose, headache, sore throat, a general feeling of unwellness, etc.
  • 30. What are the precautions that need to be taken to protect from the coronavirus? • A. Cover your nose and mouth when sneezing. B. Add more garlic into your diet. C. Visit your doctor for antibiotics treatment D. Wash your hands after every hour. Ans. A Explanation: According to WHO, a person can take precautions by covering the nose and mouth while sneezing via tissue or an elbow. Then, immediately throw the tissue into a closed dustbin.
  • 31. A vaccine stimulates your immune system to produce antibodies, like it would if you were exposed to the virus. • True • False
  • 32. Which of the following diseases are related to coronavirus? • A. MERS B. SARS C. Both A and B D. Neither A nor B Ans. C Explanation: Coronavirus may cause illness from the common cold to more other serious diseases like Middle East Respiratory Syndrome (MERS- CoV) and Severe Acute Respiratory Syndrome (SARS-CoV).
  • 33. • What happens to a person suffering from COVID-19? A. Around 80% of the people will require no treatment as such and will recover on their own. B. Around <20% or a small proportion may need hospitalisation. C. A very small proportion basically suffering from chronic illness may need admission in an Intensive Care Unit (ICU). D. All the above are correct Ans. D Explanation: A person who develops COVID-19: The majority of the people (80%) does not require treatment and will recover on their own, a small proportion (<20%) may need hospitalisation and a very small proportion who are underlying chronic illness may need to admit in an ICU.
  • 34. There are currently vaccines for the following coronaviruses: • SARS • MERS • SARS and MERS • None of the above
  • 35. How many vaccine candidates for COVID-19 have been proposed? • 25 % • 50% • 100% • More than 200 %
  • 36. The virus is mutating rapidly. • True • False:
  • 37. World Health Organisation on 11 February, 2020 announced an official name for the disease that is causing the 2019 novel coronavirus outbreak? What is the new name of the disease? • A. COVID-19 B. COVn-19 C. COnV-20 D. COnVID-19 Ans. A Explanation: WHO named the disease that is caused by the novel coronavirus as COVID-
  • 38. How does weather seem to affect the novel coronavirus? • The virus can’t survive in hot, humid climates. • Cold temperatures can kill the virus. • It is not yet known.
  • 39. Currently, which group has had more severe effects of COVID-19? • Men • Women • Children • Oldage
  • 40. What is quarantine ? • Quarantine is used for anyone who is a contact of someone infected with the SARS- CoV-2 virus, which causes COVID-19, whether the infected person has symptoms or not. • For COVID-19, this means staying in the facility or at home for 14 days.
  • 41. What is isolation ? • Isolation is used for people with COVID-19 symptoms or who have tested positive for the virus. Being in isolation means being separated from other people, ideally in a medically facility where you can receive clinical care. Minimum 10 days plus 3 days
  • 42. What are the complications? • Complications leading to death may include respiratory failure, acute respiratory distress syndrome (ARDS), sepsis and septic shock, thromboembolism, and/or multiorgan failure, including injury of the heart, liver or kidneys.
  • 43. • How many countries, areas, or territories are suffering from novel coronavirus outbreaks in the World? A. More than 50 B. More than 100 C. More than 150 D. More than 200 Ans. D Explanation: According to WHO, around 216 countries, areas or territories are suffering from novel coronavirus or COVID-19 outbreak in the world till 11 June, 2020.
  • 44. • Thailand announced that it has proceeded to test it's novel coronavirus vaccine on which animal/bird? A. Monkeys B. Lizards C. Hens D. Kites Ans. A Explanation: After seeing positive results on mice now Thailand announced that it has proceeded to test its novel coronavirus vaccine on monkeys. The vaccine uses messenger RNA (mRNA) technology to weaken the strain of the virus and produce antigens to fight with the virus from the root.
  • 45. • In a study, which cells are found in COVID-19 patients 'bode well' for long-term immunity? A. P-cell B. D-Cell C. T-Cell D. Endothelial Cells Ans. C Explanation: T cells are known as immune warriors help us fight some viruses, but their importance for battling SARS-CoV-2, the virus that causes COVID-19, has been unclear. Research is going on and maybe it can be fruitful.
  • 46. COVID-19 has currently been detected on all seven continents. • True • False • When the arogya set up formed in India? • A.25 march 2020 • B.1 April 2020 • C.2April 2020 • D.10 April 2020
  • 47. • Name a clinical trial in which blood is transfused from recovered COVID-19 patients to a coronavirus patient who is in critical condition? A. Plasma Therapy B. Solidarity C. Remdesivir D. Hydroxychloroquine Ans. A Explanation: Plasma Therapy or Convalescent Plasma Therapy is a clinical trial in which blood is transfused from recovered COVID-19 patients to a coronavirus patient who is in critical condition.
  • 48. Name the vaccine that is jointly developed by the German company BioNTech and US pharma giant Pfizer for COVID- 19? A. BNT162 B. PICOVACC C. Both A and B D. Neither A nor B Ans. A Explanation: BNT162 is jointly developed by the German company BioNTech and US pharma giant Pfizer. It is a group of four potential vaccines based on the messenger RNA or mRNA, concept. On the other hand, PICOVACC is an inactivated vaccine developed by the private biopharma company Sinovac. These vaccines are in clinical trial phases.
  • 49. • Which of the following statement is/are correct about Favipiravir? A. Favipiravir is an antiviral COVID-19 drug. B. Glenmark Pharmaceuticals under the brand name FabiFlu has launched an antiviral drug Favipiravir. C. It is India's first COVID-19 drug launched, priced at Rs 103 per tablet. D. All the above are correct Ans. D Explanation: Favipiravir is an antiviral COVID-19 drug. Glenmark Pharmaceuticals under the brand name FabiFlu has launched an antiviral drug Favipiravir. It is India's first COVID-19 drug launched, priced at Rs 103 per tablet.
  • 50. • In India, when did the second phase of COVID-19 vaccination start? • A. December 2020 B. January 2021 C. February 2021 D. March 2021 • Ans. D • Explanation: On 1 March, 2021, the second phase of vaccination started in India that allows all Indians above the age of 60 and Indians between the age of 45 and 59 with comorbidities to be vaccinated.
  • 51. • Which of the following are the causes of Yellow Fungus infection? • 1. Poor hygiene 2. Moisture and heat 3. Contaminated food 4. Overuse of steroids • A. 1 and 4 B. 2, 3 and 4 C. 1, 2 and 3 D. 1, 2, 3 and 4 • Ans. D • Explanation: • The causes of Yellow Fungus infection are poor hygiene, moisture and heat, contaminated food and overuse of steroids.
  • 52. When the vaccine program started ? • The first mass vaccination programme started in early December 2020 and the number of vaccination doses administered is updated on a daily basis . • The Pfizer/BioNtech Comirnaty vaccine was listed for WHO Emergency Use Listing (EUL) on 31 December 2020. • The SII/Covishield and AstraZeneca/AZD1222 vaccines (developed by AstraZeneca/Oxford and manufactured by the Serum Institute of India and SK Bio respectively) were given EUL on 16 February.
  • 53. • The Janssen/Ad26.COV 2.S developed by Johnson & Johnson, was listed for EUL on 12 March 2021. • The Moderna COVID-19 vaccine (mRNA 1273) was listed for EUL on 30 April 2021 and the Sinopharm COVID-19 vaccine was listed for EUL on 7 May 2021.
  • 54. Dose of vaccine? • One dose • Two dose • Three dose • Booster dose
  • 55. Route and frequency of covid vaccine? • SC/ 30 days • SC/28 days • SC/3 month • SC/14 days
  • 56. THANK YOU • Give your valuble likes • Comments, share,